MET and gastric carcinoma: Point mutations of MET were found in both hereditary and sporadic papillary renal cancer (Schmidt et al., 1997) and gastric carcinoma (Lee et al., 2000), in childhood liver carcinoma (Park et al., 1999), and lymph node metastases of head and neck squamous carcinoma (Di Renzo et al., 2000).